14,493 Shares in Colgate-Palmolive Company $CL Purchased by Fairtree Asset Management Pty Ltd

Fairtree Asset Management Pty Ltd acquired a new stake in Colgate-Palmolive Company (NYSE:CL) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 14,493 shares of the company’s stock, valued at approximately $1,145,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. increased its position in shares of Colgate-Palmolive by 8,040.1% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 4,655,987 shares of the company’s stock valued at $380,666,000 after buying an additional 4,598,789 shares in the last quarter. Diamond Hill Capital Management Inc. boosted its position in shares of Colgate-Palmolive by 46.7% in the 3rd quarter. Diamond Hill Capital Management Inc. now owns 8,077,549 shares of the company’s stock worth $645,719,000 after buying an additional 2,572,796 shares in the last quarter. Amundi grew its stake in Colgate-Palmolive by 41.6% in the 3rd quarter. Amundi now owns 6,294,445 shares of the company’s stock valued at $487,505,000 after acquiring an additional 1,850,412 shares during the last quarter. Two Sigma Investments LP increased its holdings in Colgate-Palmolive by 360.9% during the 3rd quarter. Two Sigma Investments LP now owns 2,126,249 shares of the company’s stock valued at $169,972,000 after acquiring an additional 1,664,949 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in Colgate-Palmolive by 3,896.0% during the fourth quarter. SG Americas Securities LLC now owns 1,189,005 shares of the company’s stock worth $93,955,000 after acquiring an additional 1,159,250 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL opened at $90.00 on Wednesday. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The company’s 50 day simple moving average is $86.17 and its 200 day simple moving average is $84.92. The company has a market capitalization of $72.21 billion, a price-to-earnings ratio of 35.02, a PEG ratio of 4.67 and a beta of 0.31. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. Colgate-Palmolive’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.91 EPS. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.82 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were given a $0.53 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Morgan Stanley reaffirmed an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Citigroup lifted their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Bank of America dropped their price target on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Twelve analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.